is there an oral semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients US FDA accepts Novo Nordisk's

While GLP-1 shots are generally well-tolerated, some patients may experience side effects that make it difficult or undesirable to continue treatment

Some phenotypes plausibly need a slower-than-label climb: lighter bodies (higher exposure per milligram), a history of severe GLP-1 gut intolerance, a high baseline heart rate, or a lean, low-reserve build

What to Do Next Not sure if your results are on track or if something needs adjusting

Third, exploring personalized medicine approaches that account for genetic, epigenetic, and environmental factors influencing ferroptosis will enable the development of tailored therapies for individual patients